Angus Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANGUS, and what generic and branded alternatives to ANGUS drugs are available?
ANGUS has two approved drugs.
Drugs and US Patents for Angus
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Angus | TETRACHEL | tetracycline hydrochloride | CAPSULE;ORAL | 060343-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Angus | MYCHEL-S | chloramphenicol sodium succinate | INJECTABLE;INJECTION | 060132-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Angus | TETRACHEL | tetracycline hydrochloride | CAPSULE;ORAL | 060343-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.